1. Non-small cell lung cancer;DS Ettinger;J Natl Compr Canc Netw,2010
2. Cancer statistics, 2020.;RL Siegel;CA: a cancer journal for clinicians.,2020
3. Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.;D Morgensztern;J Thorac Oncol.,2015
4. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.;A Rittmeyer;Lancet (London, England).,2016
5. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer;M Reck;The New England journal of medicine,2016